Cargando…

Modification of fatty acids composition in erythrocytes lipids in arterial hypertension associated with dyslipidemia

BACKGROUND: Modification of fatty acids (FA) composition in erythrocytes lipids as an early indicator of the development of arterial hypertension (AH) and lipid disorders. METHODS: We included 34 patients with arterial hypertension and 11 healthy individuals. Each patient was examined the lipid comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Novgorodtseva, Tatyana P, Kantur, Tatyana A, Karaman, Yulia K, Antonyuk, Marina V, Zhukova, Natalia V
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038133/
https://www.ncbi.nlm.nih.gov/pubmed/21255401
http://dx.doi.org/10.1186/1476-511X-10-18
_version_ 1782198052188061696
author Novgorodtseva, Tatyana P
Kantur, Tatyana A
Karaman, Yulia K
Antonyuk, Marina V
Zhukova, Natalia V
author_facet Novgorodtseva, Tatyana P
Kantur, Tatyana A
Karaman, Yulia K
Antonyuk, Marina V
Zhukova, Natalia V
author_sort Novgorodtseva, Tatyana P
collection PubMed
description BACKGROUND: Modification of fatty acids (FA) composition in erythrocytes lipids as an early indicator of the development of arterial hypertension (AH) and lipid disorders. METHODS: We included 34 patients with arterial hypertension and 11 healthy individuals. Each patient was examined the lipid composition of serum. From erythrocytes by gas chromatography were identified fatty acids. The quantitative composition of the erythrocyte lipids FA in patients with AH presented with saturated and polyunsaturated monoenic acids with carbon chain lengths from C12 to C22. RESULTS: In all hypertensive patients is disturbed lipid FA composition of erythrocytes. The patients with a normal level of serum lipids revealed deficiency of polyunsaturated acids n6-linoleic (18:2 n6), arachidonic (20:4 n6), dokozatetraenic 14,4% (22:4 n6). The patients with dislipidemia installed more profound restructuring of the lipid matrix of the membrane of erythrocytes. A decrease in polyunsaturated fatty acids family n3: dokozapentaenovoy (22:5 n3), docosahexaenoic PUFA (22:6 n3), the total value of n3 PUFA in 1,3 times was revealed. CONCLUSION: Thus, modification of erythrocyte FA are fairly subtle indicator of pathology of lipid metabolism, which manifest themselves much earlier than changes in the lipoprotein of blood plasma.
format Text
id pubmed-3038133
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30381332011-02-13 Modification of fatty acids composition in erythrocytes lipids in arterial hypertension associated with dyslipidemia Novgorodtseva, Tatyana P Kantur, Tatyana A Karaman, Yulia K Antonyuk, Marina V Zhukova, Natalia V Lipids Health Dis Review BACKGROUND: Modification of fatty acids (FA) composition in erythrocytes lipids as an early indicator of the development of arterial hypertension (AH) and lipid disorders. METHODS: We included 34 patients with arterial hypertension and 11 healthy individuals. Each patient was examined the lipid composition of serum. From erythrocytes by gas chromatography were identified fatty acids. The quantitative composition of the erythrocyte lipids FA in patients with AH presented with saturated and polyunsaturated monoenic acids with carbon chain lengths from C12 to C22. RESULTS: In all hypertensive patients is disturbed lipid FA composition of erythrocytes. The patients with a normal level of serum lipids revealed deficiency of polyunsaturated acids n6-linoleic (18:2 n6), arachidonic (20:4 n6), dokozatetraenic 14,4% (22:4 n6). The patients with dislipidemia installed more profound restructuring of the lipid matrix of the membrane of erythrocytes. A decrease in polyunsaturated fatty acids family n3: dokozapentaenovoy (22:5 n3), docosahexaenoic PUFA (22:6 n3), the total value of n3 PUFA in 1,3 times was revealed. CONCLUSION: Thus, modification of erythrocyte FA are fairly subtle indicator of pathology of lipid metabolism, which manifest themselves much earlier than changes in the lipoprotein of blood plasma. BioMed Central 2011-01-21 /pmc/articles/PMC3038133/ /pubmed/21255401 http://dx.doi.org/10.1186/1476-511X-10-18 Text en Copyright ©2011 Novgorodtseva et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Novgorodtseva, Tatyana P
Kantur, Tatyana A
Karaman, Yulia K
Antonyuk, Marina V
Zhukova, Natalia V
Modification of fatty acids composition in erythrocytes lipids in arterial hypertension associated with dyslipidemia
title Modification of fatty acids composition in erythrocytes lipids in arterial hypertension associated with dyslipidemia
title_full Modification of fatty acids composition in erythrocytes lipids in arterial hypertension associated with dyslipidemia
title_fullStr Modification of fatty acids composition in erythrocytes lipids in arterial hypertension associated with dyslipidemia
title_full_unstemmed Modification of fatty acids composition in erythrocytes lipids in arterial hypertension associated with dyslipidemia
title_short Modification of fatty acids composition in erythrocytes lipids in arterial hypertension associated with dyslipidemia
title_sort modification of fatty acids composition in erythrocytes lipids in arterial hypertension associated with dyslipidemia
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038133/
https://www.ncbi.nlm.nih.gov/pubmed/21255401
http://dx.doi.org/10.1186/1476-511X-10-18
work_keys_str_mv AT novgorodtsevatatyanap modificationoffattyacidscompositioninerythrocyteslipidsinarterialhypertensionassociatedwithdyslipidemia
AT kanturtatyanaa modificationoffattyacidscompositioninerythrocyteslipidsinarterialhypertensionassociatedwithdyslipidemia
AT karamanyuliak modificationoffattyacidscompositioninerythrocyteslipidsinarterialhypertensionassociatedwithdyslipidemia
AT antonyukmarinav modificationoffattyacidscompositioninerythrocyteslipidsinarterialhypertensionassociatedwithdyslipidemia
AT zhukovanataliav modificationoffattyacidscompositioninerythrocyteslipidsinarterialhypertensionassociatedwithdyslipidemia